Navigation Links
Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
Date:10/3/2007

ation of escalating doses of TPI 287 and temozolomide, both orally administered, in tumors of the central nervous system.

At the meeting of the American Society of Clinical Oncology in June 2007, the Company reported interim data from two Phase 1 studies, each evaluating a different dosing regimen for the compound. The data demonstrated the safety and tolerability of TPI 287 in both schedules, and included evidence of anti- tumor activity in four patients at or near the maximum tolerated dose in three different tumor types.

About Pancreatic Cancer

Pancreatic cancer is a tumor that forms in the pancreas, a small, thin gland located behind other organs in the abdomen. Pancreatic cancer is difficult to detect and diagnose due to a lack of noticeable symptoms of the disease in its early stages. For newly diagnosed patients who are eligible for surgical treatment of the disease, surgery is typically followed by a combination of radiation and chemotherapy. Patients whose disease has become inoperable because of extensive local spread of the disease receive a combination of radiation and chemotherapy. Advanced stage patients with more widespread or metastatic disease are generally treated with chemotherapy alone. In patients with inoperable cancer, therapy is only palliative, which means that it only slows the disease's progress rather than providing a cure. Gemcitabine is approved as the initial chemotherapy for patients with inoperable pancreatic cancer. Other drugs are only marginally effective, including fluoropyrimidine and Tarceva (erlotinib).

About TPI 287

TPI 287, a proprietary next-generation taxane, is Tapestry's lead clinical compound. This compound was designed to overcome multiple drug resistance in solid tumors that are innately resistant to taxane therapy or have become resistant to taxanes following exposure to chemotherapy drugs. In preclinical testing, TPI 287 demonstrated the ability to inhibit tumor cell growth in a number
'/>"/>

SOURCE Tapestry Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007 AACR Annual Meeting
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  B. Braun Medical Inc. (B.Braun) ... safety with products, services and education focused on ... innovative Outlook® 400ES and Space Infusion Systems, and ... the American Association of Critical-Care Nurses (AACN) National ... Boston Convention Center. ...
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- It is no secret that Americans have ... or obese gyms and supplement companies are in line to ... primarily related to dietary issues and a lack of physical ... a glandular problem or even a vitamin deficiency. ... is a lack of vitamin b12 . The vitamin ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... Lines for Therapeutic ... Cloning, ... to report, and painstakingly document, the cloning of a,human embryo using donated ... study was published online today by the journal "Stem,Cells.", (Logo: ...
... Cataract surgery involves,removing a clouded natural lens from ... While the operation itself hasn,t changed much over recent,years, ... newer lenses,is their ability to reduce the need for ... Medical School., The Aging Eye: Preventing and Treating ...
Cached Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery 2
(Date:5/20/2013)... Bradley, Illinois (PRWEB) May 20, 2013 ... assisted living community in Lake County, Illinois, is hosting ... 24. , The community, which is located at 3775 ... all incomes, including those on Medicaid, who need some ... our delicious breakfast buffet and games of bingo," says ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 The ... product type into two categories - semi-automated and ... is classified into five categories, namely, hospitals, pre-hospital, ... is forecast till 2017. Automated external defibrillators play ... sudden cardiac arrest victims. Considering the life-saving potential ...
(Date:5/20/2013)... Minneapolis, MN (PRWEB) May 20, 2013 When ... right bed is only part of the process. Much of ... over the internet involves not knowing what to expect. ... expert advice consumers can use to ensure their purchase proves ... When You Buy a Mattress Online ”, readers find helpful ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to treat ... as if not treated, it may involve the ureter and ... urinary tract infection in itself is not life threatening, if ... pyelonephritis. Women seem to have many more urinary tract infections ... as women after the age of fifty. , As ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Fastcare Advises on How to Prevent a UTI 2
... for Home Oxygen Therapy to Less Than Half of 1997 ... prepare to celebrate the New Year, the home oxygen community ... Medicare policy changes that will present many challenges to beneficiaries ... in the form of a 36-month cap on payments for ...
... WASHINGTON, Dec. 31 Each Sunday throughout January, ... that tells the compelling and inspirational stories of ... six-time Grammy Award winner Naomi Judd. Sharing Miracles ... across the United States. Judd, one-half of the ...
... Ltd. (NYSE Alternext,US: SVA), a leading provider of vaccines ... the Company,s inactivated hepatitis A vaccine,Healive(R), following a report ... District,in the City of Beijing on November 27, 2008. ... autopsy results, the death was caused by,myocarditis, an inflammation ...
... Calif., Dec. 31 Watson Pharmaceuticals, Inc. (NYSE: ... and specialty branded pharmaceuticals, today announced that its ... the United States Food and Drug Administration to ... mint flavor, in the 2 mg and 4 ...
... to Dock, a U.S. based Non-Governmental Organization (NGO), sent over $3,000,000 ... ... (Vocus) December 31, 2008 -- In a continent often ... attention paid to the many uplifting success stories. Among ...
... biopsy is still considered the gold standard for grading, ... it remains a primary source for acquiring new knowledge ... the fibrosis and inflammatory tissue detectable in liver biopsy ... the closest-to-real effects of new antiviral molecules on the ...
Cached Medicine News:Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 2Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 2Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 4Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 5Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 6Health News:Sinovac Announces that Government Investigation Rules Out Healive's Role in Child's Death 2Health News:Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum 2Health News:Good News in Africa: Beyond the headlines 2Health News:A rigorous method for liver biopsy 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: